Skip to main content

Introduction: History of psoriasis and psoriasis therapy

  • Chapter
Book cover Treatment of Psoriasis

Part of the book series: Milestones in Drug Therapy ((MDT))

Abstract

This chronicle of psoriasis begins in ancient times when psoriasis, leprosy, and other inflammatory skin disorders were thought to be the same condition. The identification of psoriasis as a distinct entity did not occur until the 19th century, when clinical descriptions distinguished it from other cutaneous disorders. Histopathologic descriptions in the 1960s and 1970s shed some light on the pathophysiology of psoriasis, but many aspects of the disease remain unknown to this day. As Bechet expressed, “Psoriasis is an antidote for dermatologists’ ego” [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bechet PE (1936) Psoriasis, a brief historical review. Arch Dermatol Syph 33: 327–334

    Google Scholar 

  2. Hebra F (1868) On disease of the skin. New Sydenham Society, London

    Google Scholar 

  3. Fox H (1915) Dermatology of the ancients. JAMA 65: 469

    Google Scholar 

  4. Sutton RL (1986) Sixteenth century physician and his methods mercurialis on diseases of the skin. The Lowell Press, Kansas City, MO

    Google Scholar 

  5. Pusey WA (1933) The history of dermatology. Charles C Thomas, Springfield, IL

    Google Scholar 

  6. Glickman FS (1986) Lepra, psora, psoriasis. J Am Acad Dermatol 14(5 Pt 1): 863–866

    PubMed  CAS  Google Scholar 

  7. Celsus AC (1837) De re medica. East Portwine, London

    Google Scholar 

  8. Willan, R (1809) On Cutaneous Diseases. Kimber and Conrad, Philadelphia

    Google Scholar 

  9. Rayer P (1835) Treatises on diseases of the skin. 2nd ed. J.B. Bailliere, London

    Google Scholar 

  10. Gibert CM (1840) Traite pratique des maladies speciales de la peau. 2nd ed. Germer-Bailliere, Paris

    Google Scholar 

  11. Wilson E (1863) Diseases of the skin. Blanchchard and Lea, Philadelphia

    Google Scholar 

  12. Fox T (1871) Skin diseases: Their description, pathology, diagnosis, and treatment. William Wood and Co, New York

    Google Scholar 

  13. Milton JL (1872) Diseases of the skin. Robert Hardwicke, London

    Google Scholar 

  14. Crissey JT, Parish LC, Shelley WB (1981) The dermatology and syphilology of the nineteenth century. Praiger Publishers, New York

    Google Scholar 

  15. Hebra on F, Kaposi M (1876) Lehrbuch der Hautkrankheiten. Ferdinanand Euke, Stuttgart

    Google Scholar 

  16. Fry L (1988) Psoriasis. Br J Dermatol 119(4): 445–461

    Article  PubMed  CAS  Google Scholar 

  17. Farber EM (1982) Historical Commentary. In: EM Farber, AJ Cox, L Nall, PH Jacobs (eds): Psoriasis: proceedings of the Third International Symposium, Stanford University, 1981. Third ed. Grune and Stratton, New York, 7–11

    Google Scholar 

  18. Köbner H (1876) Zur Aetiologie der Psoriasis. Vjschr Dermatol 3: 559–561

    Google Scholar 

  19. von Zumbusch LR (1910) Psoriasis und pustuloses exanthem. Archives of Dermatology and Syphiliology 99: 335–346

    Article  Google Scholar 

  20. Woronoff DL (1926) Die peripheren Veränderungen der Haut um die Effloreszenzen der Psoriasis vulgaris und Syphilis corymbosa. Dermatologische Wochenschrift 82: 249–257

    Google Scholar 

  21. VanScott EJ, Ekel TM (1963) Kinetics of hyperplasia in psoriasis. Arch Dermatol 88: 373–381

    PubMed  CAS  Google Scholar 

  22. Weinstein GD, Van Scott EJ (1966) Turnover time of human normal and psoriatic epidermis by autoradiographic analysis. J Inves Dermatol 45: 561–567

    Google Scholar 

  23. Gubner R (1951) Effect of aminopterin on epithelial tissues. AMA Arch Derm Syphilol 64(6): 688–699

    PubMed  CAS  Google Scholar 

  24. Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis. N Engl J Med 301(10): 555

    PubMed  CAS  Google Scholar 

  25. Bjerke JR, Krogh HK, Matre R (1978) Characterization of mononuclear cell infiltrates in psoriatic lesions. J Invest Dermatol 71(5): 340–343

    Article  PubMed  CAS  Google Scholar 

  26. Baker BS, Swain AF, Fry L, Valdimarsson H (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110(5): 555–564

    Article  PubMed  CAS  Google Scholar 

  27. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352(18): 1899–1912

    Article  PubMed  CAS  Google Scholar 

  28. Girdlestone T (1806) Observations on the effects of Dr. Fowler’s mineral solution in lepra and other diseases. Med Phys J London 15: 298–301

    Google Scholar 

  29. Farber EM (1992) History of the treatment of psoriasis. J Am Acad Dermatol 27(4): 640–645

    Article  PubMed  CAS  Google Scholar 

  30. Duhring LA (1876) Atlas of skin diseases. JB Lippincot and Co, Philadelphia

    Google Scholar 

  31. Squire B (1876) Treatment of psoriasis by an ointment of chrysophanic acid. BMJ 819–920

    Google Scholar 

  32. Unna PG (1916) Cignolin als Heilmittel der Psoriasis. Dermatologische Wochenschrift 6: 116–137, 151–163, 175–183

    Google Scholar 

  33. Hjorth N, Norgaard M (1991) Tars. In: HH Roenigk, HL Maibach (eds): Psoriasis. Marcel Dekker, New York, 473–479

    Google Scholar 

  34. Squire B (1878) Atlas of skin diseases. JandA Churchill, London

    Google Scholar 

  35. Goeckerman WH (1925) The treatment of psoriasis. Northwest Med 25: 229–231

    Google Scholar 

  36. Ingram JT (1953) The approach to psoriasis. BMJ 2: 591–593

    Article  PubMed  CAS  Google Scholar 

  37. Lundberg IE, Grundtman C, Larsson E, Klareskog L (2004) Corticosteroids — from an idea to clinical use. Best Pract Res Clin Rheumatol 18(1): 7–19

    Article  PubMed  CAS  Google Scholar 

  38. Hench PS, Kendall EC, Slocumb CH, Polley HF (1950) Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Med Interna 85(4): 545–666

    PubMed  CAS  Google Scholar 

  39. Sulzberger MB, Witten VH (1952) The effect of topially applied compound F in selected dermatoses. J Invest Dermatol 19: 101–102

    PubMed  CAS  Google Scholar 

  40. Farber S, Diamond L, Mercer R, Sylvester R, Wolff V (1946) Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-amethopteroylglutamic acid (aminopterin). N Engl J Med 238: 787–793

    Google Scholar 

  41. Edmundson WF, Guy WB (1958) Treatment of psoriasis with folic acid antagonists. AMA Arch Derm 78(2): 200–203

    PubMed  CAS  Google Scholar 

  42. Roenigk HH Jr, Maibach HI, Weinstein GD (1973) Use of methotrexate in psoriasis. Arch Dermatol 105(3): 363–365

    Article  Google Scholar 

  43. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA (1974) Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291(23): 1207–1211

    PubMed  CAS  Google Scholar 

  44. Benedetto AV (1977) The psoralens: An historical perspective. Cutis 20: 469–471

    PubMed  CAS  Google Scholar 

  45. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 68(6): 328–335

    Article  PubMed  CAS  Google Scholar 

  46. Fischer T, Alsins J (1976) Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol 383–390

    Google Scholar 

  47. Parrish JA, Jaenicke KF (1981) Action spectrum for phototherapy of psoriasis. J Invest Dermatol 76: 359–361

    Article  PubMed  CAS  Google Scholar 

  48. Green C, Ferguson J, Lakshmipathi T, Johnson BE (1988) 311 nm UVB phototherapy — an effective treatment for psoriasis. Br J Dermatol 119(6): 691–696

    Article  PubMed  CAS  Google Scholar 

  49. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J (1992) Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 127(5): 509–512

    Article  PubMed  CAS  Google Scholar 

  50. Wolbach SB, Howe PR (1925) Tisse changes following deprivation of fat-solbe A-vitamin. J Experimental Med 42: 753–778

    Article  CAS  Google Scholar 

  51. Stuttgen G (1962) Zur Lokalbehandlung von Keratosen mit Vitamin A-Säure. Dermatologica 124: 65–80

    Article  Google Scholar 

  52. Tsambaos D, Orfanos CE (1981) Chemotherapy of psoriasis and other skin disorders with oral retinoids. Pharmacol Ther 14(3): 355–374

    Article  PubMed  CAS  Google Scholar 

  53. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS (1984) Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs 28(1): 6–37

    Article  PubMed  CAS  Google Scholar 

  54. Ellis CN, Voorhees JJ (1987) Etretinate therapy. J Am Acad Dermatol 16(2, Part 1): 267–291

    Article  PubMed  CAS  Google Scholar 

  55. Weinstein GD (1996) Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Br J Dermatol 135Suppl 49: 32–36

    Article  PubMed  CAS  Google Scholar 

  56. Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 35(3–4): 51–54

    PubMed  CAS  Google Scholar 

  57. Smith EL, Walworth NC, Holick MF (1986) Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86(6): 709–714

    Article  PubMed  CAS  Google Scholar 

  58. Kragballe K, Wildfang IL (1990) Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 282(3): 164–167

    Article  PubMed  CAS  Google Scholar 

  59. Kragballe K, Beck HI, Sogaard H (1988) Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br J Dermatol 119(2): 223–230

    Article  PubMed  CAS  Google Scholar 

  60. Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6(4): 468–475

    Article  PubMed  CAS  Google Scholar 

  61. Griffiths CE, Dubertret L, Ellis CN, Finlay AY, Finzi AF, Ho VC, Johnston A, Katsambas A, Lison AE, Naeyaert JM et al. (2004) Ciclosporin in psoriasis clinical practice: An international consensus statement. Br J Dermatol 150Suppl 67: 11–23

    Article  PubMed  CAS  Google Scholar 

  62. Ellis CN, Krueger GG (2001) Alefacept Clinical Study Group. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345(4): 248–255

    Article  PubMed  CAS  Google Scholar 

  63. Kupper TS (2003) Immunologic targets in psoriasis. N Engl J Med 349(21): 1987–1990

    Article  PubMed  CAS  Google Scholar 

  64. Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB, Etanercept Psoriasis Study Group (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349(21): 2014–2022

    Article  PubMed  CAS  Google Scholar 

  65. Lebwohl MG (2005) Advances in psoriasis. Arch Dermatol 141(12): 1589–1590

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Cowden, A., Van Voorhees, A.S. (2008). Introduction: History of psoriasis and psoriasis therapy. In: Weinberg, J.M. (eds) Treatment of Psoriasis. Milestones in Drug Therapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7724-3_1

Download citation

Publish with us

Policies and ethics